Ochsner Health
Ochsner Health System Formulary
Formulary Addition Request
Questions or Suggestions?
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
HazD
Look Alike Sound Alike
Ambulatory
Do Not Crush
REMS
Antibiotic IV Push Administration
Vaccine
SDS Online
Do Not Crush
OHS Pharmacy Contact
Louisiana Poison Control(800) 222-1222
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Ochsner Health COVID-19 SharePoint Site
"Safety On Site"
Click here
to enter an S.O.S.
Physician
Nurse
Partners
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local
pharmacy
for available inventory.
Ochsner Health
Ochsner Health System Formulary
Formulary Addition Request
Questions or Suggestions?
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
HazD
Look Alike Sound Alike
Ambulatory
Do Not Crush
REMS
Antibiotic IV Push Administration
Vaccine
SDS Online
Do Not Crush
OHS Pharmacy Contact
Louisiana Poison Control(800) 222-1222
Webpage Links
Search results for:
nivolumab-relatlimab
nivolumab-relatlimab
Drug Name
Form
Strength
Infusion Center Available
Restricted
Non-formulary
Ambulatory Available
Interchange
REMS
Opdualag
SOLUTION, INTRAVENOUS
rmbw 240 mg-80 mg/20 mL
VIEW MORE
Antineoplastic Agents
CLASS
100000
Additional Information and Links
Service line: Hematology/Oncology
Formulary location: Outpatient infusion
Service location: Outpatient infusion center
Patient population: Adult, pediatrics 12 years or older
Prior authorization Required: Yes
Restriction/Criteria of use:
Diagnosis of Stage III (unresectable) or Stage IV metastatic melanoma
No active brain metastases or leptomeningeal metastases
No diagnosis of uveal melanoma
No active, known, or suspected autoimmune disease
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
No prior systemic therapy in the unresectable or metastatic setting including chemotherapy, immunotherapy, or targeted therapy
Last updated:
Aug. 25, 2022
HazD:
Under review
UpToDate
Lexicomp
DailyMed Package Inserts
Johns Hopkins Guides